Table 1 Clinical and pathological aspects, staging and treatment of penile squamous cell carcinoma participants
| Â | N (%) |
|---|---|
Age (years) | |
 Mean (range) | 63.8 years (18–103) |
 < 40 | 17/224 (7.6) |
 40–60 | 74/224 (33.2) |
 > 60 | 133/224 (59.2) |
p16INK4a | |
 No | 174/224 (77.7) |
 Yes | 50/224 (22.3) |
hrHPV | |
 No | 88/188 (46.8) |
 Yes | 100/188 (53.2) |
Staging | |
 pTis + pTa + pT1(a.b) | 66/219 (30.1) |
 pT2 | 86/219 (39.3) |
 pT3 | 62/219 (28.3) |
 pT4 | 5/219 (2.3) |
Sistemic metastasis | |
 No | 157/188 (83.5) |
 Yes | 31/188 (16.5) |
Lymph node metastasis | |
 No | 124/207 (59.9) |
 Yes | 83/207 (40.1) |
Locoregional recurrence | |
 No | 139/188 (73.9) |
 Yes | 49/188 (26.1) |
PLI | |
 Mild and Moderate | 130/217 (59.9) |
 Intense | 87/217 (40.1) |
PPI | |
 Mild and Moderate | 205/217 (94.5) |
 Intense | 12/217 (5.5) |
ILI | |
 Mild and Moderate | 215/217 (99.1) |
 Intense | 2/217 (0.9) |
IPI | |
 Mild and Moderate | 127/217 (58.5) |
 Intense | 90/217 (41.5) |
Surgical procedure | |
 Partial amputation | 164/224 (73.2) |
 Total amputation | 33/224 (14.7) |
 Others | 27/224 (12.1) |
Chemotherapy | |
 No | 144/194 (74.2) |
 Yes | 50/194 (25.8) |
Radiotherapy | |
 No | 165/192 (85.9) |
 Yes | 27/192 (14.1) |